ClinicalTrials.gg
RecruitingNCT07466888Updated Mar 12, 2026

Effects of Frequency Adjustment in Functional Electrical Stimulation on Genioglossus Muscle Activity

An interventional study of Functional Electrical Stimulation Device in Obstructive Sleep Apnea (OSA) and Snoring, sponsored by Seoul National University Bundang Hospital. Recruiting at 1 site in South Korea. Open to participants aged 19 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-12.

Sponsored by Seoul National University Bundang Hospital · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Primary completion was expected by Mar 2026, 8 months ago, but the record still lists the study as recruiting.
  • Started Jan 2026; still recruiting 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Not applicable
Ages
19 Years and older
Sex
All
01

Study summary

This single-group interventional study investigates the safety and physiologic effects of functional electrical stimulation (FES) applied to the tongue and submental muscles in adults at high risk for sleep apnea. Participants will receive five stimulation frequencies (15, 25, 35, 45, and 75 Hz) in randomized order during a single visit. Ultrasound and tongue pressure (IOPI) measurements, as well as subjective assessments of discomfort and perceived effects, will be conducted before, during, and after stimulation. The primary objective is to evaluate changes in muscle thickness, length, and tongue strength across different stimulation frequencies. Secondary objectives include assessing participant discomfort, safety, and subjective treatment effects.

Read the detailed description

Reduced tone and weakness of the genioglossus muscle are critical factors in the pathophysiology of obstructive sleep apnea (OSA). In addition to the genioglossus, other upper airway-related muscles, including the thyrohyoid and additional infrahyoid muscles, contribute to airway stability. These muscles differ in anatomical depth from the skin surface and in muscle thickness, which necessitates differentiated electrical stimulation approaches to ensure selective activation and safety.This clinical trial is designed to evaluate the safety and efficacy of functional electrical stimulation (FES) applied to the genioglossus muscle with modulation of stimulation frequency. The study aims to determine whether frequency adjustment influences muscle morphology and functional outcomes.The primary objective is to assess frequency-dependent changes in muscle length and thickness using ultrasonography, as well as differences in tongue strength measured by the Iowa Oral Performance Instrument (IOPI) before and after electrical stimulation.The secondary objective is to evaluate discomfort, safety, and subjective treatment effects through questionnaires administered before and after the electrical stimulation intervention.

02

Conditions studied

  • Obstructive Sleep Apnea (OSA)
  • Snoring

Keywords

  • Obstructive Sleep Apnea (OSA)
  • Snoring
  • FES
03

In context

Sleep Apnea, Obstructive

2,240 studies on the registry are indexed under Sleep Apnea, Obstructive; 475 are open to participants now.

This study's planned enrollment of 28 is below the median of 52 across 1,472 interventional studies indexed under Sleep Apnea, Obstructive.

Browse Sleep Apnea, Obstructive studies →

Lead sponsor

Seoul National University Bundang Hospital is the lead sponsor of 376 studies on the registry; 56 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 19 years or older
  • STOP questionnaire score ≥ 2
  • Able to read and write in Korean
  • Voluntarily provides written to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Refusal to undergo study procedures or failure to provide
  • Cognitive impairment or psychiatric disorders that interfere with the ability to follow study instructions
  • Pregnant or breastfeeding women
  • Known allergy or to electrical stimulation pads or related materials (e.g., silicone, polypropylene, polyethylene)
  • Skin conditions preventing application of electrical stimulation (e.g., hypersensitive skin)
  • Medical conditions considered unsuitable for participation by the investigator (e.g., epilepsy, malignant tumor, high fever, diabetes mellitus, use of anticoagulants, phlebitis, thrombophlebitis, hemophilia)
  • Infectious disease or local conditions at the stimulation site (e.g., inflammation, wounds, abscess, edema)
  • Known cardiac disease or presence of a cardiac pacemaker or implanted electrical stimulation device
  • History of surgery involving the submental area or upper airway region
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
28 participants (estimated)

Study arms

  • Experimental
    Multi-frequency Functional Electrical Stimulation

    All participants receive a single-session multi-frequency functional electrical stimulation protocol (15-75 Hz) applied in randomized order. Ultrasound and tongue pressure (IOPI) measurements are performed before and after stimulation, while subjective assessments of discomfort and perceived effects are collected during each stimulation frequency. Participants are blinded to stimulation frequency.

    Device: Functional Electrical Stimulation Device

Interventions

  • DeviceFunctional Electrical Stimulation Device

    A functional electrical stimulation device is applied to the submental region using surface adhesive electrodes. Stimulation is delivered at five different frequencies (15, 25, 35, 45, and 75 Hz) in randomized sequence during a single study visit. Each frequency is administered within the same session to evaluate immediate physiologic responses of the tongue muscles. Participants are blinded to the stimulation frequency applied during each condition.

06

What researchers measure

Primary outcomes

  1. Change in genioglossus muscle thickness measured by ultrasonography

    The thickness of the genioglossus muscle is measured using ultrasonography before and immediately after electrical stimulation at each frequency (15, 25, 35, 45, and 75 Hz) during a single study visit.

    Time frame: Before and immediately after stimulation at each frequency during a single study visit (~1 hour)

  2. Change in genioglossus muscle length measured by ultrasonography

    The length of the genioglossus muscle is measured using ultrasonography before and immediately after electrical stimulation at each frequency (15, 25, 35, 45, and 75 Hz) during a single study visit.

    Time frame: Before and immediately after stimulation at each frequency during a single study visit (~1 hour)

  3. Change in tongue strength measured by the Iowa Oral Performance Instrument (IOPI)

    Tongue strength is measured using the Iowa Oral Performance Instrument (IOPI) in kilopascals (kPa) before electrical stimulation and immediately after completion of all frequency conditions during a single study visit (\~1 hour). IOPI scores range from 0 kPa (no measurable pressure) to approximately 70 kPa (maximum tongue strength), with higher scores indicating greater tongue strength.

    Time frame: Before stimulation and immediately after completion of all frequency conditions during a single study visit (~1 hour)

Secondary outcomes

  1. Participant-reported discomfort associated with electrical stimulation

    Participant discomfort is assessed using a 1-5 Likert scale questionnaire during each stimulation frequency and immediately after completion of all frequency conditions during the study visit (\~1 hour). Scale interpretation: 1 = very uncomfortable, 2 = uncomfortable, 3 = neutral, 4 = comfortable, 5 = very comfortable. Higher scores indicate greater comfort.

    Time frame: During each stimulation frequency and immediately after completion of all frequency conditions during a single study visit (~1 hour)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07466888
Collaborators
National Research Foundation of Korea
Responsible party
JeeHyun Suh (Professor, Seoul National University Bundang Hospital) — Principal investigator
First posted
Mar 12, 2026
Start date
Jan 6, 2026
Primary completion
Mar 2026 (estimated)
Completion
Apr 2026 (estimated)
Last update
Mar 12, 2026

Study contacts

Juseok Ryu, M.D., Ph.D.
Contact
jseok337@snu.ac.kr
+82-31-787-7739
Hyunjin KIM
Contact
+82-10-9974-7152
Jee Hyun Suh, M.D., Ph.D.
principal investigator · Seoul National University Bundang Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion